- Home
- HEPS vs EVMN Comparison
HEPS vs EVMN Comparison
Compare HEPS & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HEPS | EVMN |
|---|---|---|
| Founded | 2000 | 2020 |
| Country | Turkey | United States |
| Employees | N/A | 48 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 825.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HEPS | EVMN |
|---|---|---|
| Price | $2.64 | $19.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $3.07 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 381.9K | 367.5K |
| Earning Date | 05-07-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.29 | N/A |
| Revenue Next Year | $27.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $13.89 |
| 52 Week High | $3.30 | $33.20 |
Technical Indicators
Market Signals| Indicator | HEPS | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 35.16 |
| Support Level | $2.52 | $18.00 |
| Resistance Level | $2.93 | $21.21 |
| Average True Range (ATR) | 0.11 | 1.37 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 44.20 | 2.16 |
Price Performance
Historical ComparisonAbout HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.